Dr. Rakesh Patel is a renowned oncologist with a special interest in breast cancer, genomics, and precision medicine. He serves as Chair of the Multi-disciplinary Breast Cancer and High-risk Programs at Good Samaritan Hospital. Dr Patel has given over 250 lectureships around the globe and is a co-founder in a leading nationwide Breast Cancer KOL think tank. He has led multiple healthcare startups focusing on clinical gaps, care coordination, real-world data, and patient engagement. He is a co-founder of Medneon, an AI digital health provider platform for cancer risk assessment and management which was acquired by Invitae in 2021. He now serves as the Chief Medical Officer of Digital Health for Invitae.
Clinical Dx Showcase:
Our genes can transform our health. Invitae's mission is to bring genetics to mainstream medicine to improve healthcare for billions.
Clinical Decision Support Tools in Oncology
There is a large amount of genetic information and novel therapies that are now available and keeping providers updated of the rapidly changing guidelines for risk assessment, genetic testing and management can be challenging.
The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative